Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,455.00
-25.70 (-1.04%)
Oct 8, 2025, 1:03 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 1.02 trillion as of October 7, 2025. Its market cap has increased by 6.68% in one year.
Market Cap
1.02T
Enterprise Value
1.09T
Revenue
129.10B
Ranking
n/a
PE Ratio
53.44
Stock Price
2,455.00
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 1.02T, an increase of 79.71%. That is a compound annual growth rate of 27.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 1,023.93B | -13.84% |
| Dec 31, 2024 | 1,188.36B | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,966.34B |
| Divi's Laboratories | 1,620.55B |
| Cipla | 1,222.39B |
| Apollo Hospitals Enterprise | 1,107.14B |
| Zydus Lifesciences | 1,000.85B |
| Fortis Healthcare | 786.52B |
| Alkem Laboratories | 656.89B |
| Aurobindo Pharma | 633.13B |